Cargando…

Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking

OBJECTIVE: This study aimed to decipher the bioactive compounds and potential mechanism of traditional Chinese medicine (TCM) formula Fuzi Lizhong Decoction (FLD) for nonalcoholic fatty liver disease (NAFLD) treatment via an integrative network pharmacology approach. METHODS: The candidate compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zheng, Xia, Lu-Yun, Tang, Yu-Qin, Huang, Lili, Liu, Dan, Huai, Wen-Ying, Zhang, Chun-Jiang, Wang, Yan-Qiu, Xie, Yong-Mei, Yin, Qiao-Zhi, Chen, Yun-Hui, Zhang, Tian-E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794673/
https://www.ncbi.nlm.nih.gov/pubmed/35096103
http://dx.doi.org/10.1155/2022/1670014
_version_ 1784640866419212288
author Luo, Zheng
Xia, Lu-Yun
Tang, Yu-Qin
Huang, Lili
Liu, Dan
Huai, Wen-Ying
Zhang, Chun-Jiang
Wang, Yan-Qiu
Xie, Yong-Mei
Yin, Qiao-Zhi
Chen, Yun-Hui
Zhang, Tian-E.
author_facet Luo, Zheng
Xia, Lu-Yun
Tang, Yu-Qin
Huang, Lili
Liu, Dan
Huai, Wen-Ying
Zhang, Chun-Jiang
Wang, Yan-Qiu
Xie, Yong-Mei
Yin, Qiao-Zhi
Chen, Yun-Hui
Zhang, Tian-E.
author_sort Luo, Zheng
collection PubMed
description OBJECTIVE: This study aimed to decipher the bioactive compounds and potential mechanism of traditional Chinese medicine (TCM) formula Fuzi Lizhong Decoction (FLD) for nonalcoholic fatty liver disease (NAFLD) treatment via an integrative network pharmacology approach. METHODS: The candidate compounds of FLD and its relative targets were obtained from the TCMSP and PharmMapper web server, and the intersection genes for NAFLD were discerned using OMIM, GeneCards, and DisGeNET. Then, the PPI and component-target-pathway networks were constructed. Moreover, GO enrichment and KEGG pathway analysis were performed to investigate the potential signaling pathways associated with FLD's effect on NAFLD. Eventually, molecular docking simulation was carried out to validate the binding affinity between potential core components and key targets. RESULTS: A total of 143 candidate active compounds and 129 relative drug targets were obtained, in which 61 targets were overlapped with NAFLD. The PPI network analysis identified ALB, MAPK1, CASP3, MARK8, and AR as key targets, mainly focusing on cellular response to organic cyclic compound, steroid metabolic process, and response to steroid hormone in the biological processes. The KEGG pathway analysis demonstrated that 16 signaling pathways were closely correlated with FLD's effect on NALFD with cancer pathways, Th17 cell differentiation, and IL-17 signaling pathways as the most significant ones. In addition, the molecular docking analysis revealed that the core active compounds of FLD, such as 3′-methoxyglabridin, chrysanthemaxanthin, and Gancaonin H, had a high binding activity with such key targets as ALB, MAPK1, and CASP3. CONCLUSIONS: This study suggested that FLD exerted its effect on NAFLD via modulating multitargets with multicompounds through multipathways. It also demonstrated that the network pharmacology-based approach might provide insights for understanding the interrelationship between complex diseases and interventions of the TCM formula.
format Online
Article
Text
id pubmed-8794673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87946732022-01-28 Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking Luo, Zheng Xia, Lu-Yun Tang, Yu-Qin Huang, Lili Liu, Dan Huai, Wen-Ying Zhang, Chun-Jiang Wang, Yan-Qiu Xie, Yong-Mei Yin, Qiao-Zhi Chen, Yun-Hui Zhang, Tian-E. Evid Based Complement Alternat Med Research Article OBJECTIVE: This study aimed to decipher the bioactive compounds and potential mechanism of traditional Chinese medicine (TCM) formula Fuzi Lizhong Decoction (FLD) for nonalcoholic fatty liver disease (NAFLD) treatment via an integrative network pharmacology approach. METHODS: The candidate compounds of FLD and its relative targets were obtained from the TCMSP and PharmMapper web server, and the intersection genes for NAFLD were discerned using OMIM, GeneCards, and DisGeNET. Then, the PPI and component-target-pathway networks were constructed. Moreover, GO enrichment and KEGG pathway analysis were performed to investigate the potential signaling pathways associated with FLD's effect on NAFLD. Eventually, molecular docking simulation was carried out to validate the binding affinity between potential core components and key targets. RESULTS: A total of 143 candidate active compounds and 129 relative drug targets were obtained, in which 61 targets were overlapped with NAFLD. The PPI network analysis identified ALB, MAPK1, CASP3, MARK8, and AR as key targets, mainly focusing on cellular response to organic cyclic compound, steroid metabolic process, and response to steroid hormone in the biological processes. The KEGG pathway analysis demonstrated that 16 signaling pathways were closely correlated with FLD's effect on NALFD with cancer pathways, Th17 cell differentiation, and IL-17 signaling pathways as the most significant ones. In addition, the molecular docking analysis revealed that the core active compounds of FLD, such as 3′-methoxyglabridin, chrysanthemaxanthin, and Gancaonin H, had a high binding activity with such key targets as ALB, MAPK1, and CASP3. CONCLUSIONS: This study suggested that FLD exerted its effect on NAFLD via modulating multitargets with multicompounds through multipathways. It also demonstrated that the network pharmacology-based approach might provide insights for understanding the interrelationship between complex diseases and interventions of the TCM formula. Hindawi 2022-01-20 /pmc/articles/PMC8794673/ /pubmed/35096103 http://dx.doi.org/10.1155/2022/1670014 Text en Copyright © 2022 Zheng Luo et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Luo, Zheng
Xia, Lu-Yun
Tang, Yu-Qin
Huang, Lili
Liu, Dan
Huai, Wen-Ying
Zhang, Chun-Jiang
Wang, Yan-Qiu
Xie, Yong-Mei
Yin, Qiao-Zhi
Chen, Yun-Hui
Zhang, Tian-E.
Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title_full Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title_fullStr Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title_full_unstemmed Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title_short Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
title_sort action mechanism underlying improvement effect of fuzi lizhong decoction on nonalcoholic fatty liver disease: a study based on network pharmacology and molecular docking
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794673/
https://www.ncbi.nlm.nih.gov/pubmed/35096103
http://dx.doi.org/10.1155/2022/1670014
work_keys_str_mv AT luozheng actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT xialuyun actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT tangyuqin actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT huanglili actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT liudan actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT huaiwenying actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT zhangchunjiang actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT wangyanqiu actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT xieyongmei actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT yinqiaozhi actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT chenyunhui actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking
AT zhangtiane actionmechanismunderlyingimprovementeffectoffuzilizhongdecoctiononnonalcoholicfattyliverdiseaseastudybasedonnetworkpharmacologyandmoleculardocking